Opendata, web and dolomites

Calcivis CAIS

Validation of clinical performance and pre-commercial development of a novel diagnostic for dental caries assessment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Calcivis CAIS project word cloud

Explore the words cloud of the Calcivis CAIS project. It provides you a very rough idea of what is the project "Calcivis CAIS" about.

imaging    cavitation    version    leads    teeth    missed    ce    unmet    fill    off    automatic    prevention    differentiation    pilot    tooth    caries    effectiveness    performance    tactile    progress    active    subjective    prognostic    unnecessarily    market    drill    clinic    moving    device    progression    ions    enabled    away    diagnosis    capability    undergoing    visual    form    lesions    accelerate    differentiate    safety    globally    free    uniquely    validate    extracted    clinical    diagnostic    first    december    detect    therapeutic    actively    recombinant    paradigm    restored    mark    granted    uses    dentistry    surface    monitoring    sophisticated    launch    photoprotein    calcium    ongoing    validation    shift    inactive    demineralisation    full    incipient    dental    examination    standards    subject    preventive    ready    prototype    date    proof    marker    detection    decay    gradually    calcivis    innovative    demineralising    2013    switching    commercial   

Project "Calcivis CAIS" data sheet

The following table provides information about the project.

Coordinator
CALCIVIS LIMITED 

Organization address
address: 9 Edinburgh BioQuarter, Little France
city: Edinburgh
postcode: EH16 4UX
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.calcivis.com
 Total cost 2˙975˙531 €
 EC max contribution 2˙615˙000 € (88%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2014
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2017-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CALCIVIS LIMITED UK (Edinburgh) coordinator 2˙615˙000.00

Map

 Project objective

The project will support development of the market ready version of the Calcivis Caries Activity Imaging System (currently in advanced prototype form) and validate its clinical performance against existing standards, which will enable first EU launch within one year of funding and US launch within two.

The Calcivis technology is a highly innovative and globally significant dental diagnostic which has the capability to enable and accelerate the ongoing paradigm shift towards preventive dentistry. Uniquely it uses a recombinant photoprotein marker and a sophisticated imaging device to detect free calcium ions at the tooth surface, to provide diagnostic and prognostic information on the development and progression of caries lesions (tooth decay).

There is a significant unmet need in dentistry to differentiate early caries lesions that are actively demineralising from those that are less likely to progress to cavitation. Current state of the art is subjective visual/tactile examination which leads to active lesions being missed and inactive lesions being unnecessarily restored. Dental practice is gradually moving towards diagnosis/prevention and away from automatic ‘drill and fill’ approaches; a shift which will be further enabled by the Calcivis System.

It is the only product that can directly detect ongoing demineralisation in the clinic which enables: - differentiation of active from inactive lesions - early detection of incipient active lesions - monitoring of therapeutic effectiveness i.e. ‘switching off’ of activity

To date, a prototype of the Calcivis System has been used to demonstrate proof of concept in extracted teeth and is now undergoing a pilot safety and performance clinical study. The clinical prototype was granted a CE mark in December 2013. The results of this clinical study and ongoing market research are being used to support design of the commercial device and the full clinical validation programme, which is the subject of this application.

 Deliverables

List of deliverables.
Receipt acknowledged by FDA Documents, reports 2019-07-24 15:31:51
Ethics and NHS R+D approval letter received Documents, reports 2019-07-24 15:31:51
Clinical study 1 report (interim) completed and approved Documents, reports 2019-07-24 15:31:51

Take a look to the deliverables list in detail:  detailed list of Calcivis CAIS deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CALCIVIS CAIS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CALCIVIS CAIS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More